Practice Area
Healthcare finance executives operate in a uniquely complex environment — managing revenue cycle, payor contracting, CMS compliance, and the M&A pace driven by PE consolidation simultaneously. We place the CFOs, COOs, and operational leaders who have done this work before and can do it again at your scale.
A CFO from a manufacturing company cannot step into a health system and manage revenue cycle complexity, payor contract negotiations, and 340B compliance simultaneously. A physician group COO who has only managed a single specialty cannot run the operational integration of a PE-backed multi-specialty platform. The domain specificity in healthcare leadership is real — and the candidate pools for these roles do not overlap as much as generalist recruiters assume.
Healthcare revenue cycle is a full-time discipline — coding integrity, denial management, payor contract compliance, prior authorization management, and AR days optimization are all distinct areas requiring specific expertise. A CFO who has only managed the revenue cycle as a downstream reporting function is not the same as one who has owned it operationally. This distinction matters enormously in interviews and on the job.
340B drug pricing, Medicare and Medicaid cost reports, DSH and UPL calculations, and CMS Conditions of Participation compliance are the regulatory alphabet that defines healthcare finance. These credentials take years to develop in a clinical environment and cannot be learned quickly from the outside. Candidates who arrive without them require significant infrastructure to navigate regulatory exposure.
Private equity consolidation in healthcare services has accelerated at every level — from dental groups to physician practices to behavioral health to home health. PE-backed healthcare companies operate at sponsor speed: compressed timelines, institutional reporting standards, and constant transaction readiness. This environment rewards candidates with prior PE-backed healthcare experience and creates significant mis-hire risk for those without it.
Private equity consolidation has created a new class of healthcare finance executive demand — and a corresponding talent shortage. Here is what that means for your search.
PE-backed physician groups and specialty healthcare platforms often need their first institutional CFO — an executive who can build reporting infrastructure from scratch, satisfy sponsor reporting requirements, and position the business for an eventual exit. This is a specific profile: technically credible with healthcare-specific accounting, comfortable presenting to a PE board, and capable of building a finance function while running it simultaneously. We find these executives.
PE-backed healthcare platforms grow through acquisition. The finance and operations leaders managing these integrations need specific M&A integration experience in healthcare — practice management system conversions, payor credentialing transitions, provider compensation harmonization, and billing system unification. A CFO who has only managed organic growth is not the same as one who has integrated 10 add-ons in 3 years.
Healthcare companies approaching an exit process — whether strategic sale, secondary buyout, or IPO — need finance leadership that can support the diligence process: QofE readiness, normalized EBITDA build, provider compensation disclosure, and third-party liability estimation. This capability is often the difference between a clean process and a re-trade.
As reimbursement models shift toward value-based arrangements — ACOs, shared savings programs, capitated risk contracts — healthcare finance executives must understand the actuarial and financial modeling implications of risk-bearing contracts. This is an emerging but rapidly growing credential requirement, particularly at health systems and large physician groups entering risk arrangements.
Healthcare finance has a vocabulary that tells candidates immediately whether the recruiter calling them actually knows the work. Here is what we know.
340B Drug Pricing Program
A federal program requiring drug manufacturers to provide outpatient drugs at reduced prices to qualifying healthcare organizations. For eligible health systems and community health centers, 340B management is a significant financial function — and executives who have managed a 340B program are a meaningful and limited pool.
DSH / UPL
Disproportionate Share Hospital and Upper Payment Limit — Medicaid supplemental payment programs that can represent significant revenue for eligible hospitals and health systems. Finance executives who understand the DSH and UPL calculation and documentation requirements are sought after at every health system with a significant Medicaid payor mix.
Days in AR
Days in accounts receivable — the primary metric for revenue cycle performance. A Head of Revenue Cycle who can move days in AR meaningfully — even 3–5 days — at a large health system is managing the equivalent of tens of millions of dollars in cash conversion. This is the metric that matters most to CFOs evaluating revenue cycle leaders.
Payor Mix
The distribution of reimbursement sources — Medicare, Medicaid, commercial insurance, self-pay — at a healthcare organization. Payor mix is the primary driver of financial performance variability and is the first thing a healthcare CFO candidate asks about when evaluating a new opportunity. It tells them everything they need to know about the financial complexity of the role.
Provider Compensation Modeling
The design and maintenance of physician and APP compensation structures — productivity-based, salary, wRVU-based, and hybrid models. CFOs and VPs of Finance at physician groups are heavily involved in compensation model design. Candidates with direct provider comp modeling experience are in consistent demand as PE consolidation drives compensation harmonization across acquired practices.
CHC / CPC
Certified in Healthcare Compliance (CHC) and Certified Professional Coder (CPC) — the primary professional credentials in healthcare compliance and coding. The CHC designation is increasingly preferred (and sometimes required) at Compliance Director and CCO level, particularly at PE-backed organizations under heightened OIG scrutiny.
Tell us the role and the platform context. We'll give you a straight read on the candidate market and an honest timeline.